Literature DB >> 24068399

CD105 microvessels density, VEGF, EGFR-1 and c-erbB-2 and their prognostic correlation in different subtypes of cervical adenocarcinoma.

Ileana Barbu1, Stefania Crăiţoiu, Cristiana Eugenia Simionescu, Ana Maria Drâgnei, Cl Mărgăritescu.   

Abstract

In this study, we have investigated the immunohistochemical expression of endoglin (CD105), vascular endothelial growth factor (VEGF), epidermal growth factor receptor (EGFR-1) and epidermal growth factor receptor 2 (c-erbB-2) and their prognostic correlation in 13 cases of cervical adenocarcinomas with mucinous, endometrioid and serous type differentiation. Our study revealed that for uterine cervix adenocarcinoma the most intense angiogenic activity occurs at the invasion front of these tumors. In addition, we noticed a trend towards increased CD105 MVD values in those cases in which were recorded the highest VEGF and c-erbB-2 reactivity. Thus, we concluded that in cervical adenocarcinomas occurs an intense process of angiogenesis, mainly at the invasion front, controlled by interrelations between VEGF and EGFR family members, especially the c-erbB-2 receptor. Further studies are needed to elucidate whether specific angiogenic molecular profiles exist in different histopathological subtypes of uterine adenocarcinomas and which is their impact on prognosis and therapeutic outcomes for these patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24068399

Source DB:  PubMed          Journal:  Rom J Morphol Embryol        ISSN: 1220-0522            Impact factor:   1.033


  11 in total

Review 1.  Cancer prevention and therapy through the modulation of the tumor microenvironment.

Authors:  Stephanie C Casey; Amedeo Amedei; Katia Aquilano; Asfar S Azmi; Fabian Benencia; Dipita Bhakta; Alan E Bilsland; Chandra S Boosani; Sophie Chen; Maria Rosa Ciriolo; Sarah Crawford; Hiromasa Fujii; Alexandros G Georgakilas; Gunjan Guha; Dorota Halicka; William G Helferich; Petr Heneberg; Kanya Honoki; W Nicol Keith; Sid P Kerkar; Sulma I Mohammed; Elena Niccolai; Somaira Nowsheen; H P Vasantha Rupasinghe; Abbas Samadi; Neetu Singh; Wamidh H Talib; Vasundara Venkateswaran; Richard L Whelan; Xujuan Yang; Dean W Felsher
Journal:  Semin Cancer Biol       Date:  2015-04-10       Impact factor: 15.707

Review 2.  Exploring the therapeutic rationale for angiogenesis blockade in cervical cancer.

Authors:  Lauren S Krill; Krishnansu S Tewari
Journal:  Clin Ther       Date:  2015-01-01       Impact factor: 3.393

3.  Noninvasive brain cancer imaging with a bispecific antibody fragment, generated via click chemistry.

Authors:  Haiming Luo; Reinier Hernandez; Hao Hong; Stephen A Graves; Yunan Yang; Christopher G England; Charles P Theuer; Robert J Nickles; Weibo Cai
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-28       Impact factor: 11.205

Review 4.  Clinical Trials of Antiangiogenesis Therapy in Recurrent/Persistent and Metastatic Cervical Cancer.

Authors:  Jill K Alldredge; Krishnansu S Tewari
Journal:  Oncologist       Date:  2016-03-29

Review 5.  Prognostic value of microvessel density in cervical cancer.

Authors:  Xiaoli Hu; Hailing Liu; Miaomiao Ye; Xueqiong Zhu
Journal:  Cancer Cell Int       Date:  2018-10-03       Impact factor: 5.722

6.  In vivo synergistic anti-tumor effect of paclitaxel nanoparticles combined with radiotherapy on human cervical carcinoma.

Authors:  YanXin Yu; Shan Xu; Hong You; YinJie Zhang; Bo Yang; XiaoYang Sun; LingLin Yang; Yue Chen; ShaoZhi Fu; JingBo Wu
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

7.  Modulatory Effects of Chemoradiation on Angiogenic Factors and Laminin in Cervical Cancer: Link with Treatment Response

Authors:  Manoj Sharma; Rehan Khan; Mayank Aggarwal; Alpana Sharma
Journal:  Asian Pac J Cancer Prev       Date:  2017-11-26

8.  Expression of BDNF, TrkB, VEGF and CD105 is associated with pelvic lymph node metastasis and prognosis in IB2-stage squamous cell carcinoma.

Authors:  Yingying Qi; Weili Li; Shan Kang; Long Chen; Min Hao; Wuliang Wang; Bin Ling; Zhumei Cui; Cong Liang; Junsheng He; Xiaolin Chen; Chunlin Chen; Ping Liu
Journal:  Exp Ther Med       Date:  2019-10-14       Impact factor: 2.447

9.  Reprogramming energy metabolism and inducing angiogenesis: co-expression of monocarboxylate transporters with VEGF family members in cervical adenocarcinomas.

Authors:  Céline Pinheiro; Eduardo A Garcia; Filipa Morais-Santos; Marise A R Moreira; Fábio M Almeida; Luiz F Jubé; Geraldo S Queiroz; Élbio C Paula; Maria A Andreoli; Luisa L Villa; Adhemar Longatto-Filho; Fátima Baltazar
Journal:  BMC Cancer       Date:  2015-11-02       Impact factor: 4.430

10.  Prognostic significance of the co-expression of EGFR and HER2 in adenocarcinoma of the uterine cervix.

Authors:  Asako Ueda; Akira Takasawa; Taishi Akimoto; Kumi Takasawa; Tomoyuki Aoyama; Yoshihiko Ino; Masanori Nojima; Yusuke Ono; Masaki Murata; Makoto Osanai; Tadashi Hasegawa; Tsuyoshi Saito; Norimasa Sawada
Journal:  PLoS One       Date:  2017-08-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.